Envestnet Asset Management Inc Revolution Medicines, Inc. Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 6,123 shares of RVMD stock, worth $304,190. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,123
Previous 7,026
12.85%
Holding current value
$304,190
Previous $248,000
9.27%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RVMD
# of Institutions
334Shares Held
195MCall Options Held
908KPut Options Held
723K-
Vanguard Group Inc Valley Forge, PA15.8MShares$783 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$712 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$666 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$526 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$510 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.36B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...